Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/565907


Croatia Pharmaceuticals and Healthcare Report Q1 2008


Description: The Croatia Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Croatias pharmaceuticals and healthcare industry.

The Croatian market is small and behind many of its regional neighbours, despite its relatively advanced status. At more than 70% by value, generics - comprising mostly relatively expensive branded generics - meet the bulk of demand for pharmaceuticals, with the segment continuing to be boosted by healthcare debts, cost-containment initiatives and the support for the strong domestic generics industry in the face of distinct intellectual property (IP) deficiencies.

As in many of its regional peers, prescription medicines in Croatia account for an estimated 85% of the market, largely reflecting the underdeveloped primary care network and the status of medical professionals in the country. The aim of joining the European Union (EU) in as early as 2009 or 2010 will stimulate healthcare system reform in Croatia, gradually leading to the development of a more comprehensive primary care network. Cost-containment pressures will similarly stimulate the growth of an over-the-counter (OTC) market, although the cost-consciousness of consumers will act as a brake on the sector’s value development.

In the new Q108 Business Environment Rankings for the major 15 Central and Eastern Europe (CEE) markets, Croatia is found in joint twelfth place, alongside Lithuania, and above only Ukraine and Serbia. The current situation, therefore, is not judged particularly favourable for conducting business in the country, with other markets viewed as offering more commercial potential to multinationals. However, Croatia’s removal from the Office of the US Trade Representative (USTR)’s 2007 ‘Special 301’ report, focusing on countries in violation of intellectual property rights (IPRs), indicates a definite improvement in the country’s operating conditions.

In the meantime, the local industry remains strong. Pliva, recently acquired by US Barr, is the dominant local player, commanding around a quarter of total generics sales in the country. The acquisition will improve Pliva’s access to foreign markets and the US in particular. In the meantime, foreign direct investment (FDI) is discouraged by the country’s severe healthcare debt and delays in payments, although the government has relaxed its notoriously difficult reimbursement list inclusion policy somewhat in recent months, including more foreign-made drugs.


Contents: Executive Summary
Croatia Political SWOT
Croatia Economic SWOT
Croatia Business Environment SWOT
Business Environment Ratings
Pharmaceutical Ratings - Revised Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Croatia - Business Environment Ranking
Table: Pharmaceutical Business Environment Rankings
Limits To Potential Returns
Risks To Potential Returns
Market Summary
Regulatory Regime
Table: Croatian Product Approvals In 2006
Intellectual Property Regime
Pricing And Reimbursement Regime
Recent Pricing And Reimbursement Developments
Table: Recently Approved Medicines In Croatia
Industry Trends And Developments
Health Status
Table: Leading Causes of Death in Croatia, 2005
Healthcare Expenditure
Healthcare Debts
Healthcare Reforms
Domestic Pharmaceutical Industry
Foreign Company Activities
Table: Lukaps’ Time Line
Research And Development Sector
Industry Forecast Scenario
Overall Market Forecast
Table: Drug Market Forecast
Key Growth Factors - Industry
Table: Health Expenditure Trends, 2006-2012
Key Growth Factors - Macroeconomic
Table: Croatia - Economic Activity
Prescription Market Forecast
Table: Prescription Market Forecast, 2006-2012 (US$mn unless otherwise stated)
OTC Market Forecast
Table: OTC Market, 2006-2012 (US$mn unless otherwise stated)
Generics And Patented Medicines Market Forecast
Table: Generics Market Forecast
Export/Import Forecasts
Table: Trade Figures (US$mn)
Other Healthcare Forecasts
Table: Other Healthcare Forecasts
Key Risks To Our Forecast Scenario
Competitive Landscape
Table: Market Shares Of Leading Companies (2004)
Company Monitor
International Company Profiles
GlaxoSmithKline
Pfizer
Sanofi-Aventis
Novartis
Merck & Co
Krka
Indigenous Company Profiles
Pliva
Belupo
Our Forecast Modelling
How We Generate Our Industry Forecasts
Pharmaceutical Industry
Sources


Companies Mentioned - Belupo - GlaxoSmithKline - Krka - Merck & Co - Novartis - Pfizer - Pliva - Sanofi-Aventis


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/565907

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/02/2012 04:55:57
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Croatia Pharmaceuticals and Healthcare Report Q1 2008
Web Address:
http://www.researchandmarkets.com/reports/565907
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €393.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 16/02/2012 04:55:57

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)